DVPSASDILOCUKU-BFLUCZKCSA-N
C30H43ClN2O5Si — CID 86666750
Data last refreshed: (MolForge compound catalog, from PubChem)
About DVPSASDILOCUKU-BFLUCZKCSA-N
DVPSASDILOCUKU-BFLUCZKCSA-N (PubChem CID 86666750) has the molecular formula C30H43ClN2O5Si and a molecular weight of 575.22 g/mol. Its IUPAC name is tert-butyl (2R,5S)-2-[(R)-[tert-butyl(dimethyl)silyl]oxy-(6-chloro-3-pyridinyl)methyl]-5-[(4-methoxycarbonylphenyl)methyl]pyrrolidine-1-carboxylate.
Molecular Properties
| Compound Name | DVPSASDILOCUKU-BFLUCZKCSA-N |
|---|---|
| PubChem CID | 86666750 |
| Molecular Formula | C30H43ClN2O5Si |
| Molecular Weight | 575.22 g/mol |
| Exact Mass | 574.26 |
| IUPAC Name | tert-butyl (2R,5S)-2-[(R)-[tert-butyl(dimethyl)silyl]oxy-(6-chloro-3-pyridinyl)methyl]-5-[(4-methoxycarbonylphenyl)methyl]pyrrolidine-1-carboxylate |
| SMILES | COC(=O)c1ccc(C[C@@H]2CC[C@H]([C@H](O[Si](C)(C)C(C)(C)C)c3ccc(Cl)nc3)N2C(=O)OC(C)(C)C)cc1 |
| InChI | InChI=1S/C30H43ClN2O5Si/c1-29(2,3)37-28(35)33-23(18-20-10-12-21(13-11-20)27(34)36-7)15-16-24(33)26(22-14-17-25(31)32-19-22)38-39(8,9)30(4,5)6/h10-14,17,19,23-24,26H,15-16,18H2,1-9H3/t23-,24+,26+/m0/s1 |
| InChIKey | DVPSASDILOCUKU-BFLUCZKCSA-N |
| XLogP | 7.60 |
| TPSA | 77.96 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 575.22 |
| LogP ≤ 5 | 7.60 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 86666750 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.